Adamsson 2018 [37] | BaHammam 2003 [28] | BaHammam 2005 [29] | BaHammam 2013 [30] | Buchowski 2009 [32] | Cooper 2016 [25] | Friborg 2012 [39] | Garde 2014 [38] | Lehnkering 2007 [35] | Lloyd 2013 [33] | Ludy 2018 [40] | O’Connell 2014 [34] | Pechova 2019 [26] | Shochat 2019 [36] | Suzuki 2019 [41] | Tonetti 2013 [27] | Waterhouse 2009 [31] | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Question | Responses | ||||||||||||||||
3. Was the exposure measured in a valid and reliable way? | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
4. Were confounding factors identified? | ✗ | ✗ | ✗ | ✗ | ✓ | ✗ | ✗ | ✓ | ✗ | ✗ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
5. Were strategies to deal with confounding factors stated? | ✗ | ✗ | ✗ | ✗ | ✓ | ✗ | ✗ | ✓ | ✗ | ✗ | ✗ | ✓ | ✓ | ✓ | ✓ | ✓ | U |
7. Were the outcomes measured in a valid and reliable way? | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | U | ✓ | U |
8. Was the follow-up time reported and sufficient to be long enough for outcomes to occur? | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✗ |
9. Was follow up complete, and if not, were the reasons to loss to follow up described and explored? | ✗ | ✗ | ✓ | ✓ | ✓ | ✗ | ✗ | ✗ | ✓ | ✗ | ✗ | ✓ | ✓ | ✗ | ✗ | ✓ | U |
10. Were strategies to address incomplete follow up utilized? | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | U | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | U |
11. Was appropriate statistical analysis used? | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |